CN106421531A - Medicinal composition for treating infant yang jaundice syndromes - Google Patents
Medicinal composition for treating infant yang jaundice syndromes Download PDFInfo
- Publication number
- CN106421531A CN106421531A CN201611082517.5A CN201611082517A CN106421531A CN 106421531 A CN106421531 A CN 106421531A CN 201611082517 A CN201611082517 A CN 201611082517A CN 106421531 A CN106421531 A CN 106421531A
- Authority
- CN
- China
- Prior art keywords
- herba artemisiae
- medicinal composition
- infant
- yang jaundice
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal composition for treating infant yang jaundice syndromes. The medicinal composition is characterized by comprising sweet wormwood, jasmines, oriental wormwood, coix seeds and poria cocos; the sweet wormwood and brown sugar are fried together, and the jasmines, the oriental wormwood, the coix seeds and the poria cocos are dried herbs on the market. The medicinal composition has the advantages that the medicinal composition clears damp and heat, soothes liver-gallbladder and has remarkable curative effect, patients can be cured after taking one dose or three doses, side effect is small, and the medicinal composition is easy to popularize.
Description
Technical field
The invention belongs to technical field of Chinese medicines, it is related to a kind of pharmaceutical composition treating infant YANG jaundice disease.
Background technology
The sickness rate of infant jaundice had rising trend in recent years, and this is had with environment now, diet, such as:Anemia of pregnant woman eats
Excessive greasy, pungent product, cool thing, then plus varieties of food items additive, residue in the chemical fertilizer of food, the factor such as pesticide.
Jaundice Chinese medicine is divided into two kinds:
(One)YANG jaundice:It mostly is damp-heat accumulation liver and gall and causes, liver and gall lose its logical fall, excessive jaundice, and YANG jaundice sickness rate is many, Yi Zhi.Yellow
As orange, yellow distinctness is clear to, and children easily cry and scream, and is apt to breast, yellow urine, HUANGBAI(sic) of defecating, and minority has abdominal distention, vomiting, and aphtha refers to
How blue or green stricture of vagina is, and tongue is partially red;
(Two)YIN jaundice:Mostly be congenital spleen sun not enough, damp and hot interior tired, dysfunction of the spleen in transportation, lead to pregnant jaundice to be difficult to send, prolonged do not move back, cloudy
Yellow sickness rate is low, but is difficult to treat.Its Huang is secretly blue or green, heavy then blue or green Guizhou Province, distention and fullness in the abdomen, vomiting, and loose stool color is white, cold hand and foot, dispirited not
Shake, spiritual indolent and listless, lack of appetite pale tongue, the light volt of fingerprint, weak pulse is micro-.
Therapeutic Method has phototherapy and medicine to treat at present.Phototherapy is the blue light (cold light source) using wavelength 420~460mm, can
Continue or indirect irradiation 24~48 hours.Light therapy treatment neonatal jaundice is easy to use, and untoward reaction is little, in clinic
Apply to extensive.The useful tin mesoporphyrin of Drug therapy is treated, and its code name is (SnMP).It is current U.S. food and medication management
Office (FDA) is approved for clinical only haemachrome analog.Heme oxygenase (HO) is that heme catabolism produces bilirubin
Rate-limiting enzyme, suppression Heme oxygenase (H0) activity can reduce bilirubinic generation, therefore in neonatal liver to bilirubin
When processing function is not yet ripe, there is reasonability using this medical instrument.
The effect that clinically phototherapy has is bad, and tin mesoporphyrin type is single, and action time, section was limited.
Content of the invention
It is an object of the present invention to provide a kind of good effect, the low medicine of side effect, for treating infant YANG jaundice disease.
The technical scheme is that:A kind of pharmaceutical composition treating infant YANG jaundice disease, including following medicine:Blue or green
Artemisia, Fructus Gardeniae, Herba Artemisiae Scopariae, Semen Coiciss, Poria;, with frying, Fructus Gardeniae, Herba Artemisiae Scopariae, Semen Coiciss, Poria are commercially available dry medicine for Herba Artemisiae Annuae and brown sugar.
Specifically, each drug weight part proportioning is Herba Artemisiae Annuae 6-8 part, Fructus Gardeniae 3-6 part, Herba Artemisiae Scopariae 3-7 part, Semen Coiciss 3-8 part, Fu
Siberian cocklebur 3-8 part.
Further, each drug weight part proportioning is 6 parts of Herba Artemisiae Annuae, 3 parts of Fructus Gardeniae, 6 parts of Herba Artemisiae Scopariae, 5 parts of Semen Coiciss, 4 parts of Poria.
Further, also Ramulus Uncariae Cum Uncis 4-7 part or Flos Caryophylli 2-4 part.
Wherein, Herba Artemisiae Annuae:Pungent, bitter, temperature;Return liver, gallbladder meridian.Function:Clearing away heat-damp and promoting diuresis, jaundice eliminating.
Fructus Gardeniae:Hardship, trembles with fear;GUIXIN, lung, stomach, tri-jiao channel.Function:Clearing away heat-damp and promoting diuresis, lead to the fire of fall three Jiao.
Herba Artemisiae Scopariae:Hardship, is slightly cold;Returns spleen, stomach, liver, gallbladder meridian.Function:Clearing away heat-damp and promoting diuresis.
Semen Coiciss:Sweet, light, it is slightly cold;Returns spleen, stomach, lung meridian.Function:Promoting diuresis to eliminate damp pathogen, spleen invigorating.
Poria:Sweet, light, put down;GUIXIN, spleen, kidney channel.Function:Promoting diuresis to eliminate damp pathogen, spleen invigorating.
Ramulus Uncariae Cum Uncis:Sweet in the mouth, slight bitter, cold nature;Return liver, heart channel.Function:The flat liver of heat-clearing, relieving spasm by subduing liver-wind.
Flos Caryophylli:Pungent, temperature;Return stomach, spleen, kidney channel.Function:Warming middle-JIAO, warming the kidney, sending down the abnormal ascending QI.
Pharmacology analysis:Herba Artemisiae Annuae in side, Herba Artemisiae Scopariae, toil is used in combination, eliminating damp-heat, promoting the function of the gallbladder to alleviate jaundice.Poria, Semen Coiciss, aromatization
Wet, manage wet spleen invigorating.Fructus Gardeniae heat-clearing and dampness-resolving.Ramulus Uncariae Cum Uncis relieving spasm by subduing liver-wind.Flos Caryophylli controls singultuss, vomiting, regurgitation.
The invention has the beneficial effects as follows:This side's eliminating damp-heat, depressed liver-energy dispersing and function of gallbladder promoting, evident in efficacy, one at least, at most three doses can
Cure, Small side effects are it is easy to promote.
Specific embodiment
With reference to embodiments the present invention is illustrated
Embodiment 1
A kind of pharmaceutical composition treating infant YANG jaundice disease, including following medicine:Herba Artemisiae Annuae, Fructus Gardeniae, Herba Artemisiae Scopariae, Semen Coiciss, Poria;
, with frying, Fructus Gardeniae, Herba Artemisiae Scopariae, Semen Coiciss, Poria are commercially available dry medicine for Herba Artemisiae Annuae and brown sugar.Each component is according to the concrete state of an illness of patient in above-mentioned model
Enclose interior fine setting.Can decoction, or decoct, filtering liquid medicine adds other adjuvants and makes powder, pill, electuary etc..
According to treatment case statistics, taken off as effective observation caliber using yellow, the total effective rate taking this prescription is
100%.
Embodiment 2
Lee, female, is born 15 days.First visit:Face and the yellow such as orange of eyelid, yellow distinctness is clear to, and does not cry, and breast is normal.It is diagnosed as
YANG jaundice disease.Administration:Every dose of medicine has Herba Artemisiae Annuae 6g(Also it is HUANGSONG, fresh is preferred, mix with brown sugar and fry), Fructus Gardeniae 3g, Herba Artemisiae Scopariae 6g, Semen Coiciss
Core 5 g, Poria 4 g, one decoction, obtain medicinal liquid, fed with little spoon, feed one spoonful every one to two hour.Huang takes off substantially two days later
Most, and two doses, recovery from illness.
Embodiment 3
Wang, man, is born 20 days.Its mother states:Turn to be yellow after children's birth, in hospital's phototherapy after three days, face also slightly point jaundice,
See less problematic, just go home, after going home, just rolled several days with raw egg(Folk prescription among the people).Cross and about first quarter moon, found that children are more next
More yellow, and with crying and screaming(Stomachache), go back again infantile convulsion, the phenomenon of vomiting.Come here and be diagnosed as YANG jaundice disease.Administration:Herba Artemisiae Annuae 8g, Cape jasmine
Sub- 6g, Herba Artemisiae Scopariae 7g, Semen Coiciss 8g, Poria 8g, Ramulus Uncariae Cum Uncis 4g, Flos Caryophylli 2g, as one.Decoct, obtain medicinal liquid, fed with little spoon, often
Feed one spoonful every one to two hour.Take three doses and fully recover.
Claims (6)
1. a kind of pharmaceutical composition treating infant YANG jaundice disease, is characterized in that:Including following medicine:Herba Artemisiae Annuae, Fructus Gardeniae, Herba Artemisiae Scopariae,
Semen Coiciss, Poria;, with frying, Fructus Gardeniae, Herba Artemisiae Scopariae, Semen Coiciss, Poria are commercially available dry medicine for Herba Artemisiae Annuae and brown sugar.
2. the pharmaceutical composition for the treatment of infant YANG jaundice disease according to claim 1, is characterized in that:Each drug weight part is joined
Than for Herba Artemisiae Annuae 6-8 part, Fructus Gardeniae 3-6 part, Herba Artemisiae Scopariae 3-7 part, Semen Coiciss 3-8 part, Poria 3-8 part.
3. the pharmaceutical composition for the treatment of infant YANG jaundice disease according to claim 2, is characterized in that:Each drug weight part is joined
Than for 6 parts of Herba Artemisiae Annuae, 3 parts of Fructus Gardeniae, 6 parts of Herba Artemisiae Scopariae, 5 parts of Semen Coiciss, 4 parts of Poria.
4. the pharmaceutical composition for the treatment of infant YANG jaundice disease according to claim 2, is characterized in that:Also has Ramulus Uncariae Cum Uncis 4-7 part.
5. the pharmaceutical composition for the treatment of infant YANG jaundice disease according to claim 2, is characterized in that:Also has Flos Caryophylli 2-4 part.
6. the pharmaceutical composition for the treatment of infant YANG jaundice disease according to claim 2, is characterized in that:Also have Ramulus Uncariae Cum Uncis 4-7 part,
Flos Caryophylli 2-4 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611082517.5A CN106421531A (en) | 2016-11-30 | 2016-11-30 | Medicinal composition for treating infant yang jaundice syndromes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611082517.5A CN106421531A (en) | 2016-11-30 | 2016-11-30 | Medicinal composition for treating infant yang jaundice syndromes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106421531A true CN106421531A (en) | 2017-02-22 |
Family
ID=58223175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611082517.5A Withdrawn CN106421531A (en) | 2016-11-30 | 2016-11-30 | Medicinal composition for treating infant yang jaundice syndromes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106421531A (en) |
-
2016
- 2016-11-30 CN CN201611082517.5A patent/CN106421531A/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
银羽: "茵陈汤治疗新生儿黄疸疗效观察", 《邯郸医学高等专科学校学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091282B (en) | Medicament for treating chronic gastritis and gastric ulcer | |
CN102430092A (en) | Traditional Chinese medicine composite for treating stomach cold and stomachache | |
CN102949630B (en) | Traditional Chinese medicine composition for treating abdominal distension caused by lack of gastrointestinal motility | |
CN106421383A (en) | Anticancer traditional Chinese medicine composition | |
CN103356946A (en) | Children's traditional Chinese medicinal preparation for spleen and stomach reinforcing, qi rectifying and stagnation transforming | |
CN100528204C (en) | Medicament for treating children's infantile malnutrition symptom | |
CN108403993A (en) | A kind of traditional Chinese powder medicine and preparation method thereof for treating insufficiency of the spleen diarrhoea | |
CN102613335A (en) | Food therapy pearl milk tea preparation with effects of regulating flow of Qi and removing stagnation, strengthening spleen, helping digestion and nourishing stomach | |
CN103110702A (en) | Navel-warming paste capable of warming spleen and stomach for dispelling cold and preparation method thereof | |
CN103830653A (en) | Pure traditional Chinese medicine preparation for treating infantile persistent diarrhea and preparation method thereof | |
CN103212003A (en) | Medicine and food capable of treating hot and damp diarrhea | |
WO2018006642A1 (en) | Tcm drug for treating pregnant women suffering from spleen deficiency and dampness stagnation | |
CN106421531A (en) | Medicinal composition for treating infant yang jaundice syndromes | |
CN106421051A (en) | Traditional Chinese medicine for treating peptic ulcer | |
CN1062470C (en) | Chinese medicine prepn for infant anorexia | |
CN102266417B (en) | Chinese medicine for treating acquired immune deficiency syndrome and preparation method and administration method thereof | |
CN106491785A (en) | Easypro mixture of stomach and preparation method thereof | |
CN101766745A (en) | Medicine for treating gastritis and preparation method | |
CN105748832A (en) | Agentia for treating infantile diarrhea | |
CN106540148A (en) | The oral drugs for the treatment of pancreatitis and colitis gastric ulcer | |
CN104958659A (en) | Traditional Chinese medicine composition for treating infantile anorexia | |
CN104127811A (en) | Traditional Chinese medicinal composition for treating children food retention | |
CN103239697A (en) | Drug for invigorating spleen of child to arrest diarrhea and suitable for rectal infusion and preparation method thereof | |
CN102824572B (en) | Chinese medicine for expelling toxins and protecting health and preparation method thereof | |
CN106492169A (en) | A kind of pharmaceutical composition for treating infant's yin jaundice disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170222 |